V体育2025版 - 2014
DOI: 10.1182/blood-2013-12-543736
|Get access via publisher |Cite
|
Sign up to set email alerts

"V体育官网" Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

Abstract: Key Points• We report that ruxolitinib reduces murine GVHD via increased Treg numbers.• We demonstrate the potent activity of ruxolitinib treatment in patients with corticosteroidrefractory GVHD.Graft-versus-host-disease (GVHD) is a severe complication of allogeneic hematopoietic cell transplantation (allo-HCT) characterized by the production of high levels of proinflammatory cytokines. Activated Janus kinases (JAKs) are required for T-effector cell responses in different inflammatory diseases, and their block… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
316
1
9

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 387 publications
(342 citation statements)
references
References 37 publications
16
316
1
9
Order By: Relevance